Search results
Biden’s Europe Visit Puts Pressure on Macron to Fix Scholz Ties
Bloomberg via Yahoo News· 2 hours ago(Bloomberg) -- US President Joe Biden’s visit to France for the D-Day commemoration saw plenty of...
Rapport Therapeutics Prices 8M Share IPO at $17/sh By Investing.com
Investing.com· 2 days agoRapport Therapeutics, Inc. (Nasdaq: RAPP) today announced the pricing of its initial public offering...
Sterling Shepard says Baker Mayfield got the ball rolling on his signing with the Bucs
ProFootball Talk on NBC Sports via Yahoo Sports· 1 day agoBaker Mayfield and Sterling Shepard have been reunited in Tampa Bay, playing together for the first...
Rapport talks up $122M IPO to support proof-of-concept epilepsy trials
FierceBiotech· 6 days agoRapport Therapeutics is talking up a $122 million IPO, the first in a return to public market...
Death in Paradise star 'didn't look back' after deciding to quit acting
Daily Express· 11 hours agoSergeant JP Hooper, portrayed by Tobi Bakare, bid farewell to Death in Paradise at the conclusion of...
Third Rock’s Rapport reveals upsized $154M IPO
FierceBiotech· 2 days agoJust a few days after Rapport Therapeutics revealed plans for a $122 million IPO, the epilepsy biotech has unveiled an upsized $154 million offering....
J&J-backed Rapport Therapeutics valued at $636.8 mln in lukewarm debut
Reuters· 2 days agoJohnson & Johnson-backed Rapport Therapeutics' shares rose nearly 6% above the initial public offering price on Friday, in a tepid debut for the early-stage therapy developer.
Letters to the editor
Gannett via AOL· 6 hours agoHer previous work experience includes processing payroll as well as accounts payable and cash management in dining services at Springfield College. Jen...
Mets owner Steve Cohen says fans 'have been through worse,' eyes turnaround
Associated Press via Yahoo Sports· 1 hour agoNew York Mets owner Steve Cohen says his team can still turn around its season and fans “have been...
Rapport Therapeutics raises up to $154 million in IPO - Boston Business Journal
The Business Journals· 2 days agoRapport Therapeutics Inc. said late Thursday it has raised $154 million in an initial public offering. Rapport (Nasdaq: RAPP), a Boston-based maker of small-molecule ...
